News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News AHA 2024 GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes Michael O'Riordan November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2022 Drug Preconditioning Before CABG, Valve Surgery Shows Promise: START Todd Neale November 14, 2022
News Conference News AHA 2022 Botulinum Toxin Injections No Help for Postoperative AF: NOVA Yael L. Maxwell November 07, 2022
News Conference News AHA 2022 RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years Yael L. Maxwell November 06, 2022
News Conference News AHA 2021 No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis Michael O'Riordan November 15, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018
News Conference News AHA 2016 The ART of CABG: Bilateral Technique Associated With Similar Outcomes as Single Graft at 5 Years Yael L. Maxwell November 14, 2016
News Conference News AHA 2016 Estudio ART sobre CABG: La Técnica Bilateral se Asocia a Resultados Similares a los del Injerto Único a los 5 Años Yael L. Maxwell November 14, 2016
News Conference News AHA 2015 At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation L.A. McKeown November 08, 2015
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012